Back to Bills

National Strategy for Young Adult Cancers

Full Title:
Asal Sayas National Strategy on Young Adult Cancers Act

Summary#

This bill requires the Director of the National Institutes of Health (NIH) to create a national strategy on cancers in young adults (ages 18–49). The strategy must be finished within 18 months and include research priorities, a public and clinician education campaign, recommendations on screening and care, a federal coordinating committee, and an online clearinghouse of information. The stated goal is to improve prevention, early detection, treatment, and coordination of research and services for young adult cancers.

  • Main change: NIH must develop and publish the "Asal Sayas National Strategy on Young Adult Cancers" and set up a Federal Coordinating Committee.
  • NIH must inventory current federal programs and research on young adult cancers.
  • The strategy must include a national education campaign for the public and many types of clinicians.
  • The strategy must set research priorities across basic, clinical, behavioral, and environmental areas, and recommend steps on screening, diagnostics, therapies, prevention, and support needs (fertility, mental health, employment).
  • The bill requires an online federal clearinghouse with information for the public, patients, providers, and researchers.
  • The coordinating committee must include many federal health agencies, research agencies, industry and academic representatives, and patient advocates, and must report progress at least every two years.

What it means for you#

  • Patients and caregivers (young adults, ages 18–49): Could get easier access to up-to-date information about symptoms, risk factors, screening, clinical trials, and care resources through a federal clearinghouse. The strategy calls for attention to fertility, mental health, and work-related issues during treatment.
  • Health care professionals: Primary care, emergency, OB/GYN, pulmonary, gastrointestinal, and other clinicians may see new education materials and guidance on young adult cancer signs and risk factors. The bill urges better use of tools (like electronic health records) to spot risks.
  • Researchers and academic institutions: NIH must list existing research and identify priorities and gaps. The bill encourages multi-institute research, biomarker work, and precision medicine research, which could change funding and research directions.
  • Hospitals and cancer centers: The bill recommends creating National Centers of Excellence (or a comparable program) for young adult cancers to support research, care, and education. This could lead to new programs or designations.
  • Federal agencies: Many agencies (CDC, FDA, CMS, VA, DoD, NIH institutes, EPA, NSF, etc.) are asked to coordinate through the Federal Coordinating Committee and to collaborate on research and public health actions.
  • Insurers and screening programs: The strategy will recommend ways to reduce insurance barriers to screening for young adults. The bill asks for timely review of screening recommendations by the U.S. Preventive Services Task Force, but it does not itself change coverage rules.
  • General public: Could see national education campaigns about symptoms and risk factors for cancers that are rising in younger people.

Expenses#

No publicly available information.

  • The bill does not include specific funding or an appropriation in the text.
  • This could mean NIH and other agencies would need to use existing budgets or seek new funds to develop the strategy, run education campaigns, maintain the clearinghouse, and support the coordinating committee.
  • Creating and operating National Centers of Excellence, running public campaigns, and updating an online clearinghouse could require staff, IT, and grant or contract dollars. The bill does not state how those costs would be covered.
  • Federal agencies asked to participate may incur administrative and coordination costs.

Proponents' View#

  • The bill appears intended to respond to rising cancer rates and deaths among people ages 18–49 by improving coordination of research, detection, and care.
  • It aims to reduce delays in diagnosis by educating the public and clinicians about symptoms and risk factors for cancers occurring in younger adults.
  • The bill appears intended to direct research attention to gaps in causes, early detection, biomarkers, and targeted treatments specific to young adult cancers.
  • Centralizing information in an online clearinghouse could make it easier for patients, caregivers, clinicians, and researchers to find guidelines, trials, and resources.
  • Establishing a Federal Coordinating Committee and Centers of Excellence could improve coordination across federal agencies, academic centers, and the private sector.

Opponents' View#

  • One concern is that the bill does not include funding. It is unclear how NIH and other agencies will pay for the work the bill requires.
  • The bill sets many tasks and broad goals but gives limited detail on how recommendations would be implemented, measured, or enforced.
  • There may be overlap with existing cancer research and public health programs. The bill does not explain how it will avoid duplication.
  • It is unclear whether recommended changes to screening guidance would lead to actual changes in insurance coverage or clinical practice, since the bill cannot compel independent bodies (like the U.S. Preventive Services Task Force) to act.
  • Broad age range (18–49) groups many different life stages and cancer risks together. The bill does not specify how priorities will be balanced within this wide group.
  • Ongoing maintenance of the clearinghouse and long-term support for Centers of Excellence could produce recurring costs not addressed in the bill.